Coming Soon

Study of RP1 in Organ and Cell Transplant Patients With Skin Cancer

This study is being done to look at the effects of an investigational drug, RP1, in patients with organ and hematopoietic cell transplant with advanced skin cancer (cutaneous squamous cell carcinoma).

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study will start enrolling soon.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Sid Sheth
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Other Cancers)

IRB Number

24-1990

ClinicalTrials.gov

NCT04349436

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.